Skip to content

Tiziana Life Sciences Ltd

TLSA

CIK 0001723069

← back to feed
Revenue (TTM)
—
FY Dec 2025
Net Income (TTM)
−$11.86M
+32.9% YoY FY Dec 2025
EPS Diluted (TTM)
−$0.11
+35.3% YoY FY Dec 2025
Gross Margin
—
FY Dec 2025
Operating Margin
—
FY Dec 2025
Net Margin
—
FY Dec 2025
Free Cash Flow (TTM)
—
FY Dec 2025
Cash
$3.72M
FY Dec 2025
Total Debt
—
FY Dec 2025
Shares Outstanding
120.51M sh
FY Dec 2025

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings